Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last A$0.08 AUD
Change Today 0.00 / 0.00%
Volume 0.0
MLA On Other Exchanges
Symbol
Exchange
OTC US
As of 12:34 AM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

medical australia ltd (MLA) Snapshot

Open
A$0.08
Previous Close
A$0.08
Day High
A$0.08
Day Low
A$0.08
52 Week High
09/22/14 - A$0.19
52 Week Low
11/10/14 - A$0.06
Market Cap
16.3M
Average Volume 10 Days
0.0
EPS TTM
A$0.0062
Shares Outstanding
204.3M
EX-Date
--
P/E TM
13.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDICAL AUSTRALIA LTD (MLA)

Related News

No related news articles were found.

medical australia ltd (MLA) Related Businessweek News

No Related Businessweek News Found

medical australia ltd (MLA) Details

Medical Australia Limited develops, manufactures, and distributes medical devices and animal health products for the healthcare industry in Australia, Asia, the United States, and the United Kingdom. The company’s products primarily include IV systems, safety, blood banking, surgical, anaesthesia, and animal stem cell products. It also provides sterile and non-sterile medical plastics for use in surgery and transfusion; and manufactures and supplies products for veterinary surgeons. In addition, the company offers various wall mounted suction devices enabling the aspiration of fluids from patients in clinical applications; oxygen therapy devices for the measurement and distribution of oxygen; and mobile, portable, and manual suction pumps for surgical, emergency, and ward applications. Further, it provides specialty centrifuges for the laboratory, education, and field work for various industries and applications. The company was formerly known as BMDI Tuta Limited and changed its name to Medical Australia Limited in October 2009. Medical Australia Limited was founded in 2001 and is headquartered in Lidcombe, Australia.

23 Employees
Last Reported Date: 09/30/14
Founded in 2001

medical australia ltd (MLA) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: A$78.1K
General Manager of Corporate Innovation
Total Annual Compensation: A$181.9K
Compensation as of Fiscal Year 2014.

medical australia ltd (MLA) Key Developments

Medical Australia Limited Reports Consolidated Earnings Results for the Half Year Ended Dec. 31, 2014

Medical Australia Limited reported consolidated earnings results for the half year ended Dec. 31, 2014. For the period, the company reported net profit attributable to owners of the parent entity of AUD 419,976 or 0.39 cents per diluted share compared to net loss attributable to owners of the parent entity of AUD 139,464 or 0.26 cents per diluted share reported in the same period last year. Sale of goods were AUD 7,593,618 against AUD 5,287,171 reported last year. Profit before interest and income tax was AUD 272,170 loss before interest and income tax of AUD 67,667 reported last year. Profit before income tax was AUD 282,650 loss before income tax of AUD 162,429 reported last year. Net cash used in operating activities was AUD 599,128 against AUD 602,621 reported last year. Payments for property, plant and equipment was AUD 75,907 against AUD 42,063 reported last year. Payments for intangibles were AUD 68,809. The increased revenue was due in part to a first-time revenue contribution of AUD 1.56 million from the animal healthcare business, but more significantly, from organic sales growth in the human healthcare business. EBITDA was AUD 363,502.

Medical Australia Limited to Report Q2, 2015 Results on Feb 27, 2015

Medical Australia Limited announced that they will report Q2, 2015 results on Feb 27, 2015

Medical Australia Limited Appoints Darryl Ellis as Chief Executive Officer

Medical Australia Limited announced that it has appointed Darryl Ellis to the position of Chief Executive Officer of the company, effective immediately. Mr. Ellis joined MLA in February 2014 in the capacity of Chief Operating Officer, and since this time has been instrumental in the integration of the MediVet subsidiary into the Company, significantly lowering the cost base of the combined businesses. He has also driven a program of restructure and rationalization which has enabled MLA to return to profitability.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MLA:AU A$0.08 AUD 0.00

MLA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MLA.
View Industry Companies
 

Industry Analysis

MLA

Industry Average

Valuation MLA Industry Range
Price/Earnings 12.0x
Price/Sales 0.6x
Price/Book 0.9x
Price/Cash Flow 12.1x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICAL AUSTRALIA LTD, please visit www.medaust.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.